Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.51 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.51 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.47 |
| ▸ | HSD17B1 | P14061 | 7/20 | 0.47 |
| ▸ | HSD17B2 | P37059 | 7/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.47 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.40 |
| ▸ | TYK2 | P29597 | 1/20 | 0.40 |
| ▸ | MINK1 | Q8N4C8 | 1/20 | 0.40 |
| ▸ | SRPK1 | Q96SB4 | 1/20 | 0.40 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.40 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29895961 | 0.89 | ESR1 (0.50) | ESR1ESR2GPR84HSD17B1HSD17B2 | |
| SCHEMBL29506872 | 0.89 | ESR1 (0.50) | ESR1ESR2GPR84HSD17B1HSD17B2 | |
| SCHEMBL20774057 | 0.89 | ESR1 (0.50) | ESR1ESR2GPR84HSD17B1HSD17B2 | |
| SCHEMBL28390461 | 0.89 | HSD17B1 (0.45) | ESR1ESR2GPR84HSD17B1HSD17B2 | |
| SCHEMBL26582588 | 0.87 | ESR1 (0.48) | ESR1ESR2GPR84HSD17B1HSD17B2 | |
| SCHEMBL31443100 | 0.84 | ALOX5 (0.46) | ESR1ESR2GPR84HSD17B1HSD17B2 | |
| SCHEMBL26582598 | 0.84 | MAPT (0.45) | ESR1ESR2GPR84HSD17B1HSD17B2 | |
| SCHEMBL29506873 | 0.84 | PPARD (0.52) | ESR1ESR2GPR84 | |
| SCHEMBL20774095 | 0.84 | PPARD (0.52) | ESR1ESR2GPR84 | |
| SCHEMBL30634841 | 0.84 | PPARD (0.52) | ESR1ESR2GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11952460-B2 | Polycarbonate resin, method for producing the same, and optical lens | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-04-09 | — | — | US | disclosed |
| WO-2023208837-A1 | OLIGOMERIC BINAPHTHYL COMPOUNDS AND THERMOPLASTIC RESINS | REUTER CHEMISCHE APPARATEBAU E.K. (DE) | 2023-11-02 | — | — | WO | disclosed |
| EP-4102262-A2 | THERMOPLASTIC RESIN, METHOD FOR MANUFACTURING SAME, AND OPTICAL LENS | Mitsubishi Gas Chemical Company, Inc. (JP) | 2022-12-14 | — | — | EP | disclosed |
| US-20220145004-A1 | THERMOPLASTIC RESIN, METHOD FOR MANUFACTURING SAME, AND OPTICAL LENS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2022-05-12 | — | — | US | disclosed |
| EP-3933457-A1 | THERMOPLASTIC RESIN, METHOD FOR MANUFACTURING SAME, AND OPTICAL LENS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2022-01-05 | — | — | EP | disclosed |
| US-20210355058-A1 | POLYCYCLIC COMPOUNDS | MITSUBISHI GAS CHEMICAL CO (JP) | 2021-11-18 | — | — | US | disclosed |
| US-20210340317-A1 | POLYCYCLIC COMPOUNDS | REUTER CHEMISCHE APPARATEBAU E.K. (DE) | 2021-11-04 | — | — | US | disclosed |
| EP-3677615-A1 | POLYCARBONATE RESIN, METHOD FOR PRODUCING SAME AND OPTICAL LENS | Mitsubishi Gas Chemical Company, Inc. (JP) | 2020-07-08 | — | — | EP | disclosed |
| US-20200181325-A1 | POLYCARBONATE RESIN, METHOD FOR PRODUCING THE SAME, AND OPTICAL LENS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-06-11 | — | — | US | disclosed |
| WO-2020079225-A1 | POLYCYCLIC COMPOUNDS | REUTER CHEMISCHE APPARATEBAU E.K. (DE) | 2020-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210340317-A1 | POLYCYCLIC COMPOUNDS | CBR1, C1R, CBR3 | ESR1 169/4885ESR2 157/4885GPR84 182/4885 |
| US-20210355058-A1 | POLYCYCLIC COMPOUNDS | CBR1, CBR3, C1R | ESR1 190/4885ESR2 155/4885GPR84 215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.